It's the first time the PM proteomics of OS was studied and CD151 antigen was found to be over-expressed in cell lines and confirmed its overproduction in OS clinical tissue, which was also observed to be up-regulated in breast cancer [16,17] but down-regulated in colorectal cancer [18]. This evidence concerns the gene CD151 and breast carcinoma.